3/2011
2
VIEWS-and-NEWS-A-celery-gene-may-protect-roses-from-disease-15th-European-Congress-on-Biotechnology-Environmental-Microbiology-r-nand-Biotechnology-Conference-2012-FDA-approved-first-cell-therapy-agai,85,23870,0
abstract:
VIEWS and NEWS<br>A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised £6 million • Science Multimedia Center
h3>Joanna Przybył</h3><div>BioTechnologia vol. 92(3) C pp. 221-223 C 2011
1.46537">https://doi.org/10.5114/bta.2011.46537
a>View full text</a
23870
Przybył J. VIEWS and NEWS &lt;br&gt; A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised £6 million • Science Multimedia Center. BioTechnologia. 2014;92(3):221-223. doi:10.5114/bta.2011.46537
Przybył, J. (2014). VIEWS and NEWS &lt;br&gt; A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised £6 million • Science Multimedia Center. BioTechnologia, 92(3), 221-223. https://doi.org/10.5114/bta.2011.46537
Przybył, Joanna. 2014. "VIEWS and NEWS &lt;br&gt; A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised £6 million • Science Multimedia Center". BioTechnologia 92 (3): 221-223. doi:10.5114/bta.2011.46537
Przybył, J. (2014). VIEWS and NEWS &lt;br&gt; A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised £6 million • Science Multimedia Center. BioTechnologia, 92(3), pp.221-223. https://doi.org/10.5114/bta.2011.46537
Przybył, Joanna. "VIEWS and NEWS &lt;br&gt; A celery gene may protect roses from disease • 15th European Congress on Biotechnology • Environmental Microbiology and Biotechnology Conference 2012 • FDA approved first cell therapy against wrinkles • Individualization of cancer treatment using personalized tumorgrafts • Mission Therapeutics Ltd, a new British spin-out company, raised £6 million • Science Multimedia Center." BioTechnologia, vol. 92, no. 3, 2014, pp. 221-223. doi:10.5114/bta.2011.46537
null
</div
